Literature DB >> 27056077

Genetic Association of HLA Gene Variants with MRI Brain Structure in Alzheimer's Disease.

Zi-Xuan Wang1, Yu Wan1, Lin Tan2, Jinyuan Liu3, Hui-Fu Wang4, Fu-Rong Sun1, Meng-Shan Tan1, Chen-Chen Tan1, Teng Jiang5, Lan Tan6,7, Jin-Tai Yu8,9.   

Abstract

There is accumulating evidence that the human leukocyte antigen (HLA) gene variants are associated with Alzheimer's disease (AD). However, how they affect AD occurrence is still unknown. In this study, we firstly investigated the association of gene variants in HLA gene variants and brain structures on MRI in a large sample from the Alzheimer's Disease Neuroimaging Initiative (ADNI) to explore the effects of HLA on AD pathogenesis. We selected hippocampus, hippocampus CA1 subregion, parahippocampus, posterior cingulate, precuneus, middle temporal, entorhinal cortex, and amygdala as regions of interest (ROIs). According to the previous association studies of HLA variants and AD, 12 SNPs in HLA were identified in the dataset following quality control measures. In total group analysis, our results showed that TNF-α SNPs at rs2534672 and rs2395488 were significantly positively associated with the volume of the left middle temporal lobe (rs2534672: P = 0.00035, Pc = 0.004; rs2395488: P = 0.0038, Pc = 0.023) at baseline. In the longitudinal study, HFE rs1800562 was remarkably correlated with the lower atrophy rate of right middle temporal lobe (P = 0.0003, Pc = 0.003) and RAGE rs2070600 was associated with the atrophy rate of right hippocampus substructure-CA1 over 2 years (P = 0.003, Pc = 0.035). Furthermore, we detected the above four associations in mild cognitive impairment (MCI) subgroup analysis, as well as the association of rs2534672 with the baseline volume of the left middle temporal lobe in normal cognition (NC) subgroup analysis. Our study provided preliminary evidences that HLA gene variants might participate in the structural alteration of AD associated brain regions, hence modulating the susceptibility of AD.

Entities:  

Keywords:  Alzheimer’s disease; Brain structure; Genetics; HLA; Neuroimaging

Mesh:

Substances:

Year:  2016        PMID: 27056077     DOI: 10.1007/s12035-016-9889-z

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  66 in total

Review 1.  Neural bases of learning and memory: functional neuroimaging evidence.

Authors:  R Cabeza; L Nyberg
Journal:  Curr Opin Neurol       Date:  2000-08       Impact factor: 5.710

Review 2.  Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease.

Authors:  Rashid Deane; Berislav V Zlokovic
Journal:  Curr Alzheimer Res       Date:  2007-04       Impact factor: 3.498

3.  A TAP2 genotype associated with Alzheimer's disease in APOE4 carriers.

Authors:  María J Bullido; Ana Martínez-García; María J Artiga; Jesús Aldudo; Isabel Sastre; Pedro Gil; Francisco Coria; David G Muñoz; Vladimir Hachinski; Ana Frank; Fernando Valdivieso
Journal:  Neurobiol Aging       Date:  2006-04-03       Impact factor: 4.673

Review 4.  Can infections cause Alzheimer's disease?

Authors:  Francis Mawanda; Robert Wallace
Journal:  Epidemiol Rev       Date:  2013-01-24       Impact factor: 6.222

Review 5.  Major histocompatibility complex and sporadic Alzheimer's disease: a critical reappraisal.

Authors:  Giuseppina Candore; Carmela Rita Balistreri; Giuseppina Colonna-Romano; Domenico Lio; Calogero Caruso
Journal:  Exp Gerontol       Date:  2004-04       Impact factor: 4.032

6.  Evaluation of HFE (hemochromatosis) mutations as genetic modifiers in sporadic AD and MCI.

Authors:  Daniel Berlin; George Chong; Howard Chertkow; Howard Bergman; Natalie A Phillips; Hyman M Schipper
Journal:  Neurobiol Aging       Date:  2004-04       Impact factor: 4.673

7.  Neurodegeneration in Amygdala Precedes Hippocampus in the APPswe/ PS1dE9 Mouse Model of Alzheimer's Disease.

Authors:  Tzu-Wei Lin; Yu-Fan Liu; Yao-Hsiang Shih; Shean-Jen Chen; Tung-Yi Huang; Chia-Yuan Chang; Chi-Hsiang Lien; Lung Yu; Shun-Hua Chen; Yu-Min Kuo
Journal:  Curr Alzheimer Res       Date:  2015       Impact factor: 3.498

Review 8.  Neuroinflammation in Alzheimer's disease.

Authors:  Michael T Heneka; Monica J Carson; Joseph El Khoury; Gary E Landreth; Frederic Brosseron; Douglas L Feinstein; Andreas H Jacobs; Tony Wyss-Coray; Javier Vitorica; Richard M Ransohoff; Karl Herrup; Sally A Frautschy; Bente Finsen; Guy C Brown; Alexei Verkhratsky; Koji Yamanaka; Jari Koistinaho; Eicke Latz; Annett Halle; Gabor C Petzold; Terrence Town; Dave Morgan; Mari L Shinohara; V Hugh Perry; Clive Holmes; Nicolas G Bazan; David J Brooks; Stéphane Hunot; Bertrand Joseph; Nikolaus Deigendesch; Olga Garaschuk; Erik Boddeke; Charles A Dinarello; John C Breitner; Greg M Cole; Douglas T Golenbock; Markus P Kummer
Journal:  Lancet Neurol       Date:  2015-04       Impact factor: 44.182

9.  Innate immunity and inflammation in ageing: a key for understanding age-related diseases.

Authors:  Federico Licastro; Giuseppina Candore; Domenico Lio; Elisa Porcellini; Giuseppina Colonna-Romano; Claudio Franceschi; Calogero Caruso
Journal:  Immun Ageing       Date:  2005-05-18       Impact factor: 6.400

10.  Association of HFE common mutations with Parkinson's disease, Alzheimer's disease and mild cognitive impairment in a Portuguese cohort.

Authors:  Rita J Guerreiro; Jose M Bras; Isabel Santana; Cristina Januario; Beatriz Santiago; Ana S Morgadinho; Maria H Ribeiro; John Hardy; Andrew Singleton; Catarina Oliveira
Journal:  BMC Neurol       Date:  2006-07-06       Impact factor: 2.474

View more
  10 in total

1.  The impact of Alzheimer's disease susceptibility loci on lateral ventricular surface morphology in older adults.

Authors:  Shan Li; Na An; Nan Chen; Yin Wang; Lin Yang; Yalin Wang; Zhijun Yao; Bin Hu
Journal:  Brain Struct Funct       Date:  2022-01-14       Impact factor: 3.270

Review 2.  The relationship of early- and late-onset Alzheimer's disease genes with COVID-19.

Authors:  Seda Sirin; Serap Nigdelioglu Dolanbay; Belma Aslim
Journal:  J Neural Transm (Vienna)       Date:  2022-04-16       Impact factor: 3.850

3.  Diaphanous 1 (DIAPH1) is Highly Expressed in the Aged Human Medial Temporal Cortex and Upregulated in Myeloid Cells During Alzheimer's Disease.

Authors:  Julia Derk; Keria Bermudez Hernandez; Moises Rodriguez; Meilun He; Hyunwook Koh; Andisheh Abedini; Huilin Li; David Fenyö; Ann Marie Schmidt
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 4.  Germline risk of clonal haematopoiesis.

Authors:  Alexander J Silver; Alexander G Bick; Michael R Savona
Journal:  Nat Rev Genet       Date:  2021-05-13       Impact factor: 53.242

5.  MS4A6A genotypes are associated with the atrophy rates of Alzheimer's disease related brain structures.

Authors:  Jing Ma; Wei Zhang; Lin Tan; Hui-Fu Wang; Yu Wan; Fu-Rong Sun; Chen-Chen Tan; Jin-Tai Yu; Lan Tan
Journal:  Oncotarget       Date:  2016-09-13

6.  The effects of human leukocyte antigen DRB1*13 and apolipoprotein E on age-related variability of synchronous neural interactions in healthy women.

Authors:  Lisa M James; Stacy Dolan; Arthur C Leuthold; Brian E Engdahl; Angeliki Georgopoulos; Apostolos P Georgopoulos
Journal:  EBioMedicine       Date:  2018-08-20       Impact factor: 8.143

7.  Common Neurodegeneration-Associated Proteins Are Physiologically Expressed by Human B Lymphocytes and Are Interconnected via the Inflammation/Autophagy-Related Proteins TRAF6 and SQSTM1.

Authors:  Serge Nataf; Marine Guillen; Laurent Pays
Journal:  Front Immunol       Date:  2019-11-25       Impact factor: 7.561

Review 8.  A review of brain imaging biomarker genomics in Alzheimer's disease: implementation and perspectives.

Authors:  Lanlan Li; Xianfeng Yu; Can Sheng; Xueyan Jiang; Qi Zhang; Ying Han; Jiehui Jiang
Journal:  Transl Neurodegener       Date:  2022-09-15       Impact factor: 9.883

9.  Protective Effect of Human Leukocyte Antigen (HLA) Allele DRB1*13:02 on Age-Related Brain Gray Matter Volume Reduction in Healthy Women.

Authors:  Lisa M James; Peka Christova; Scott M Lewis; Brian E Engdahl; Angeliki Georgopoulos; Apostolos P Georgopoulos
Journal:  EBioMedicine       Date:  2018-02-08       Impact factor: 8.143

10.  Evidence That HFE H63D Variant Is a Potential Disease Modifier in Cluster Headache.

Authors:  Maria Papasavva; Michail Vikelis; Martha-Spyridoula Katsarou; Vasileios Siokas; Emmanouil Dermitzakis; Christoforos Papademetriou; Konstantinos Karakostis; George Lazopoulos; Efthimios Dardiotis; Nikolaos Drakoulis
Journal:  J Mol Neurosci       Date:  2021-09-27       Impact factor: 3.444

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.